" class="no-js "lang="en-US"> Funding Archives - Medtech Alert
Wednesday, June 12, 2024

Sort by:


Top Post

Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease

An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]

Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program

Auxilius Pharma has consolidated its funding of $1 Million for developing its lead asset, AUX-001, […]

NIH Approves Second Phase of Funding to Support IND-enabling Work for Ambulero Gene Therapy to Treat Vascular Disease

Ambulero is developing a first-in-class gene and cell therapy platform for treating serious vascular diseases […]

Kate Therapeutics Debuts With $51 Million Series A to Develop Next-Generation Genetic Medicines to Treat Muscle and Heart Diseases

Kate Therapeutics, a next-generation gene therapy company, today emerged from stealth mode with a $51 […]

Nido Biosciences Emerges as Clinical Stage Company Raising $109 Million to Advance Treatments for Debilitating Neurological Diseases

Nido Biosciences, a clinical-stage company developing precision treatments for debilitating neurological diseases, emerged from stealth […]

NewBiologix Launches with $50M to Advance Novel Technology Platform for the Manufacturing of Gene and Cell Therapies

NewBiologix SA has launched today as a technology innovation company developing a proprietary and breakthrough platform […]

BRIM Plans to launch a New Funding Round to Accelerate Late-Stage Clinical Trial and Initiate a New Phase 2 Trial for Orphan Drug BRM424

BRIM Biotechnology, a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint […]

Gene & Cell Therapy Manufacturing Specialist Ascend Launches With Over $130M of Funding

Ascend Gene & Cell Therapies (Ascend), a specialist company innovating manufacturing processes to improve quality, […]

Ossium Health Awarded $3.46M in Funding from the California Institute of Regenerative Medicine

Ossium Health, announced today that the California Institute of Regenerative Medicine (CIRM) has awarded the […]

Aldena Therapeutics and Empa Awarded InnoSuisse Funding to Advance STAR Particles as a Novel Drug Delivery Technology for Dermatology

Aldena Therapeutics, a private biotech company pioneering siRNA-based therapies for dermatological indications, and Empa, the […]

Mezzion Pharma Raises Nearly $40M to Advance a First-to-Market Treatment Option for Fontan Patients

Mezzion Pharma, a rare disease-focused pharmaceutical company, announced that it has secured nearly $40M USD […]

  1. Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
  2. Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
  3. DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
  4. Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
  5. Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more